1. Home
  2. TLSA

TLSA

Tiziana Life Sciences Ltd.

Logo Tiziana Life Sciences Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
-
.
-
-
%

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of highly qualified executives with extensive drug development and commercialization experience.

Founded: 2013 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 44.1M IPO Year: 2000
Target Price: N/A AVG Volume (30 days): 66.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.15 EPS Growth: N/A
52 Week Low/High: $0.41 - $1.39 Next Earning Date: 04-30-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: